Concepedia

Pay-For-Performance Pricing for a Breakthrough Heart Drug: Learnings for Cell and Gene Therapies

Nafees N. Malik

Regenerative Medicine · 2016 · 13 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text

, , +11

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

, , +17

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

David Porter, Wei‐Ting Hwang, Noelle V. Frey et al. · Science Translational Medicine · 2015 · 1.7K citations · Full text

, , +14

$1-million price tag set for Glybera gene therapy

Chris Morrison · Nature Biotechnology · 2015 · 99 citations

, , +10

Market spiral pricing of cancer drugs

Donald W. Light, Hagop M. Kantarjian · Cancer · 2013 · 92 citations

, , +17